FRANZESE, Ciro
 Distribuzione geografica
Continente #
NA - Nord America 4.706
EU - Europa 1.046
AS - Asia 281
AF - Africa 156
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 9
Totale 6.217
Nazione #
US - Stati Uniti d'America 4.672
FI - Finlandia 290
IE - Irlanda 231
CN - Cina 182
NG - Nigeria 153
DE - Germania 117
FR - Francia 92
IT - Italia 77
SE - Svezia 74
NL - Olanda 63
GB - Regno Unito 50
CA - Canada 32
IN - India 28
TR - Turchia 25
IL - Israele 23
BE - Belgio 16
HK - Hong Kong 12
AU - Australia 9
A2 - ???statistics.table.value.countryCode.A2??? 6
CL - Cile 6
RU - Federazione Russa 6
PL - Polonia 5
RO - Romania 5
ES - Italia 4
GR - Grecia 4
IR - Iran 4
NO - Norvegia 4
AT - Austria 3
BR - Brasile 3
EU - Europa 3
BD - Bangladesh 2
EG - Egitto 2
JP - Giappone 2
MX - Messico 2
SG - Singapore 2
UA - Ucraina 2
CZ - Repubblica Ceca 1
KE - Kenya 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 6.217
Città #
Wilmington 1.079
Chandler 761
San Mateo 411
Helsinki 290
Ann Arbor 287
Dublin 230
Leawood 198
Lawrence 186
Princeton 186
Boardman 171
Shanghai 166
Benin City 153
Woodbridge 121
Fairfield 107
New York 97
Paris 91
Ashburn 90
Amsterdam 61
Milan 45
London 36
Norwalk 26
Kocaeli 25
Toronto 24
Seattle 18
Brussels 16
Monmouth Junction 16
San Diego 14
Los Angeles 13
Phoenix 12
Des Moines 10
Falkenstein 8
Pune 8
Redwood City 8
Genoa 5
Apo 4
Redmond 4
Buffalo 3
Central District 3
Clearwater 3
Cupertino 3
Hanover 3
Kemerovo 3
São Paulo 3
Vaddangi 3
Andover 2
Augusta 2
Berlin 2
Chennai 2
Collegeville 2
Eden Prairie 2
Farmington 2
Guangzhou 2
Houston 2
Jacksonville 2
Moscow 2
Niagara Falls 2
Poznan 2
Shimla 2
Singapore 2
Sydney 2
Tilburg 2
Tokyo 2
Vienna 2
Warsaw 2
Ardabil 1
Athens 1
Belleville 1
Berbenno 1
Bracknell 1
Cairo 1
Cambridge 1
Cinisello Balsamo 1
Edinburgh 1
Edmonton 1
Elk Grove Village 1
Fagnano Olona 1
Fort Simpson 1
Fountain Valley 1
Frankfurt am Main 1
Garching 1
Gosford 1
Guangling 1
Guiyang 1
Gunzenhausen 1
Hamilton 1
Hangzhou 1
Hunedoara 1
Huntington Beach 1
Iasi 1
Imola 1
Kilcoy 1
Ljubljana 1
Makkah 1
Malo 1
Manchester 1
Modesto 1
Montréal 1
Mountain View 1
Mumbai 1
Nairobi 1
Totale 5.077
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 92
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 70
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 64
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 58
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 56
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 55
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 54
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 54
Hypofractionated stereotactic radiation therapy in skull base meningiomas 53
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 53
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 52
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 51
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 51
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 51
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low-Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients. 50
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 50
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 48
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 48
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent. 47
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 46
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 46
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 46
Accuracy of fine-needle aspiration cytology in detecting cervical node metastasis after radiotherapy: Systematic review and meta-analysis 46
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 46
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 45
Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy 44
Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy 44
Results of a feed-back learning process for RapidPlan knowledge based planning 43
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 43
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 43
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 43
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 43
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 42
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 42
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 42
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 42
Critical Appraisal of the Treatment Planning Performance of Volumetric Modulated Arc Therapy by Means of a Dual Layer Stacked Multileaf Collimator for Head and Neck, Breast, and Prostate 42
Randomized phase II study of hypofractionated WBI versus APBI using VMAT: early toxicity results 42
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 42
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 Study 42
RapidPlan knowledge based planning: iterative learning process and model ability to steer planning strategies 42
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 42
RE-IRRADIATION OF LOCALLY RECURRENT PROSTATE CANCER: RESULTS OF EFFICACY AND SAFETY 41
Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. 41
SBRT for oligometastatic gynecological cancer: a single institution experience 41
Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial 41
Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer. 40
Stereotactic Body Radiation Therapy in Oligometastatic Ovarian Cancer A Promising Therapeutic Approach 40
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 40
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 40
Adenoid cystic carcinoma of the breast The double face of an exocrine gland carcinoma 40
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 39
RapidPlan head and neck model: the objectives and possible clinical benefit. 39
Role of preoperative radiotherapy in rare retroperitoneal sarcoma 39
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome. 39
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 39
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 39
HYPOFRACTIONATED RADIATION THERAPY (OVER 3 WEEKS) CAN REPLACE CONVENTIONAL RADIATION THERAPY SCHEDULE (OVER 6 WEEKS) IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS? THE TIMES ARE RIPE 39
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial (vol 13, 166, 2018) 38
Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? 38
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 38
Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question 37
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 37
Application of helical tomotherapy for the treatment of a right atrium angiosarcoma: A case report 37
Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis 37
Role of SBRT in the treatment of liver metastases: clinical results and prognostic factors 37
Imaging biomarkers in primary brain tumours 37
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 36
Role of extra cranial stereotactic body radiation therapy in the management of Stage IV melanoma 36
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 36
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 36
Role of Radiotherapy in the management of metastases from salivary gland carcinoma. 36
HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY (HSRT) IN SKULL BASE MENINGIOMAS 36
The role of SBRT in oligometastatic patients with liver metastases from breast cancer 36
External Beam Re-Irradiation of Locally Recurrent Prostate Cancer with FFF-VMAT 36
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis 36
Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease. 36
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 36
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 35
RANDOMIZED PHASE III TRIAL COMPARING GAMMA KNIFE (GK) AND LINAC BASED (EDGE) RADIOSURGERY FOR BRAIN METASTASES FROM SOLID TUMORS: RESULTS FROM THE GADGET TRIAL 35
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 35
Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution 35
Outcome Evaluation of Patients with Limited Brain Metastasis From Malignant Melanoma, Treated with Surgery, Radiation Therapy, and Targeted Therapy. 35
Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series 35
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 34
STEREOTACTIC BODY RADIATION THERAPY (SBRT) VS. MODERATE HYPOFRACTIONATED RADIOTHERAPY IN PROSTATE CANCER: PROPENSITY-SCORE BASED COMPARISON OF OUTCOME AND TOXICITY 34
VMAT SBRT For Localized Prostate Cancer: 4-Year Follow-Up And Correlation With WHO2016 Grade Groups 34
Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. 34
ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial 33
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 33
Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma 32
On the ability of a knowledge based planning process to improve itself 32
Toxicity profile of locally advanced head and neck cancer patients treated in 30 or 33 fractions RT 32
STEREOTACTIC BODY RADIATION THERAPY IN THE MANAGEMENT OF OLIGOMETASTATIC KIDNEY CANCER: NEW CHANCE OF CURE? 32
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 32
Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours. 32
Outcome evaluation of patients with diagnosed WHO grade III glioma treated according to the molecular profile, the hystology, and the extent of resection (EOR) 32
The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly. 32
Treatment: Outcome and Toxicity of Volumetric Modulated Arc Therapy in Oropharyngeal Carcinoma. 31
Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy. 31
Totale 4.154
Categoria #
all - tutte 49.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 0 0 0 0 0 0 0 0 0 0 0 68
2020/20211.962 23 18 9 17 7 601 263 149 445 220 8 202
2021/2022983 62 7 8 217 6 4 42 150 88 89 278 32
2022/20232.300 401 84 230 242 192 163 1 173 405 229 162 18
2023/20241.065 72 167 327 80 45 145 58 70 70 31 0 0
Totale 6.378